Autoimmune Dementia Profile, Spinal Fluid
Also known as: Autoimmune Dementia Panel Spinal Fluid, Paraneoplastic
Use
This test should be considered for the differential evaluation of patients who present with rapidly progressive dementia of undetermined etiology, especially with cognitive impairment and neuronal degeneration.
Special Instructions
If a reflex test is performed, additional charges and CPT code(s) may apply. It is important to consider this when ordering to avoid unexpected costs.
Limitations
The test was developed and its performance characteristics were determined by Labcorp, following CLIA requirements. It is important to note that this test has not been cleared or approved by the Food and Drug Administration, which may affect its use or interpretation in certain regulatory environments.
Methodology
Immunoassay (Immunofluorescence, Immunoblot)
Biomarkers
LOINC Codes
- 94818-2
- 56850-1
- 44768-0
- 56959-0
- 90836-8
- 14247-1
- 90843-4
- 90845-9
- 90815-2
- 63216-6
- 90827-7
- 82989-5
- 93500-7
- 96481-7
- 82735-2
- 82987-9
- 90825-1
- 82988-7
- 94711-9
- 90820-2
- 90830-1
Result Turnaround Time
4 days
Related Documents
For more information, please review the documents below
Specimen
Cerebrospinal Fluid
Volume
2 mL
Minimum Volume
1 mL
Container
Sterile plastic tube
Storage Instructions
Room temperature
Causes for Rejection
Gross hemolysis; grossly lipemic; gross icterus
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |
Other tests from different labs that may be relevant